Periodontal Disease Treatment Market Size, Growth, Share & Trends Analysis
Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Region - Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global periodontal disease treatment market, valued at USD 2.71 billion in 2025, stood at USD 2.86 billion in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of USD 3.86 billion by the end of the period. Poor oral hygiene practices, change in lifestyle, smoking habits, and the geriatric population are some of the major reasons contributing to increasing cases of periodontal diseases, hence driving the market. Greater awareness of oral health and an intensifying relationship between oral health and systemic health have encouraged many patients to visit dental health services for prevention and treatment purposes. Minimally invasive surgical treatments, laser treatment, and advanced diagnostic treatment options have facilitated the effective management of periodontal diseases; treatment has become easier and painless, thus reducing the stress associated with treatment. In addition, the growth of private dental practices and dental departments within hospitals, rising affluence, and increased emphasis on regular dental health visits will continue to drive the demand for periodontal disease treatment.
KEY TAKEAWAYS
-
By RegionBased on region, Europe accounted for a larger share of 36.2% of periodontal disease treatment market in 2025.
-
By ProductBased on product, the equipment segment accounted for a larger share of 50.6% of the periodontal disease treatment market in 2025.
-
By Disease TypeBased on disease type, in 2025, the gingivitis segment accounted for the largest share of the periodontal disease treatment market.
-
By Treatment TypeBased on treatment type, in 2025, the non-surgical treatment segment accounted for the largest share of the periodontal disease treatment market.
-
By End UserBased on end user, hospitals held the largest share of ~54.0% in the periodontal disease treatment market in 2025.
-
COMPETITIVE LANDSCAPEDentsply Sirona (US) and Henry Schein, Inc. (US) were recognized as star players due to their established strong product portfolio.
-
COMPETITIVE LANDSCAPE- STARTUPSCompanies such as Overjet have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The global periodontal disease treatment market has been witnessing significant growth, mainly as a result of a higher level of awareness about oral health, the increased occurrence of periodontal diseases, and the availability of advanced dental care solutions. Some of the key factors behind the increased incidence of gum diseases are the rising elderly population, growing number of smokers and diabetics, and the adoption of different lifestyle habits, which in turn have led to a rising demand for periodontal treatments, both preventive and therapeutic. The market is also benefiting from innovations in treatment methods, such as minimally invasive surgical procedures, the use of lasers, and the creation of new biomaterials and regenerative products.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The market for periodontal disease treatment is undergoing a massive change because of the trends and disruptions that are impacting the needs of the dental care providers and patients. A move away from the traditional consumables and medication-based revenue streams to more advanced periodontal technology, minimally invasive surgery, and digital diagnostic capabilities indicates a higher demand for early intervention, precise treatment, and chronic disease management. Hospitals, dental practices, group practices, and Dental Service Organizations (DSOs) are realizing the need for greater clinical efficiency, better workflow, minimal pain and discomfort for patients, and alignment with the increasing dental care standards. These forces are driving the need for innovative technologies and maintenance-based treatment modalities, resulting in overall superior clinical outcomes, patient satisfaction, operational efficiencies, and growth in the periodontal disease treatment market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing prevalence of oral health disorders
-
Rising cases of edentulism
Level
-
High cost of advanced treatments and inadequate reimbursements for dental procedures
Level
-
Impact of DSOs on dental industry
-
Growing awareness about oral health
Level
-
Shortage of skilled dental practitioners
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing prevalence of oral health disorders
Growth in the incidence of oral health problems is the primary factor driving the periodontal disease treatment market. The risk of periodontal diseases has been significantly elevated due to the mixture of different factors such as bad oral habits, high consumption of sugar, smoking, stress, diabetes, and aging populations. Should these diseases go untreated, the patients will be in an ever-increasing need of preventive and therapeutic periodontal treatments. The increase in oral health problems has also resulted in higher awareness among patients and doctors, which in turn leads to early diagnosis and prompt treatment, and thus, the market of periodontal disease treatment keeps expanding.
Restraint: High cost of advanced treatments and inadequate reimbursements for dental procedures
High cost of advanced therapies, as well as poor reimbursement rates for dental procedures, are some of the key factors inhibiting the growth of the periodontal disease treatment industry. Advanced periodontal therapy, such as that involving lasers, regenerative procedures, or complex surgeries, may involve expensive infrastructure. In some regions, many dental procedures may not be covered or, in some cases, may be completely excluded from standard health insurance plans. As such, many patients may have to pay out of their pockets, which may act as a deterring factor in seeking timely or advanced periodontal treatment.
Opportunity: Impact of DSOs on dental industry
The increasing presence of Dental Service Organizations (DSOs) represents an important opportunity in the periodontal disease treatment market with respect to the reformation of dental care delivery. DSOs assist dental practices by providing organization and support in relation to purchasing, technology implementation, and administration, thereby ensuring that practices function in a more effective and efficient manner and are oriented towards better patient care. DSOs with increasing presence enable greater standardization of periodontal treatment approaches, advanced technological implementation in practices, and better access to specialized care for periodontitis in various locations. In addition to this, DSOs increase patient access due to improved recognition and simpler pricing structures, along with greater recognition by various insurance providers, thereby promoting larger volumes of treatment.
Challenge: Shortage of skilled dental practitioners
The challenge of a lack of skilled dental practitioners affects the development of the periodontal disease treatment market. Both conventional and advanced treatments require specialized skills that are not available on a similar level in all regions across the world. For instance, in some developing countries, it may be hard to access periodontists and skilled dental practitioners due to limited numbers of skilled professionals, resulting in a lack of quick and effective treatment for patients with periodontal disease. This hampers the development of the periodontal disease treatment market and slows its overall growth due to a shortage of skilled dental practitioners.
PERIODONTAL DISEASE TREATMENT MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
The company manufactures resorbable or non-resorbable barrier membranes, which can be used for guided tissue regeneration or guided bone regeneration. This is done by acting as a barrier between the soft tissue and the bone, allowing cells to repopulate the area selectively. This process helps to regenerate the periodontal ligaments, cementum, and alveolar bone. | Dentsply Sirona membranes improve clinical results by facilitating predictable tissue regeneration, as well as providing better wound stability. Biocompatibility, as well as the ability to be resorbed, reduces the reliance on further surgical interventions, enhancing the efficiency of the healing process while allowing the achievement of periodontal stability. |
 |
The company has specialized in the delivery of regenerative periodontal products, biomaterials, and adjunctive regenerative devices that are used in treating periodontal defects caused by advanced gum diseases. These are usually applied in periodontic flap surgeries to help in the regeneration of bone and tissue in the affected areas and to support the tooth structure. | The regenerative solutions developed by Envista optimize predictability and promote rapid healing of tissues by improving biological integration in the defect area. The products help healthcare professionals efficiently tackle complex cases related to periodontal diseases and optimize tooth retention, thus ensuring enhanced patient satisfaction and efficiency in practices. |
 |
Institut Straumann Holdings AG has advanced tissue-regenerative materials such as biologics and biomaterials for use in periodontal regeneration. These materials are useful in regenerating periodontal structures by promoting the growth of natural tissues in the case of severe periodontitis and/or peri-implant defects. | Straumann's tissue regenerative materials enhance regenerative outcomes by encouraging bodily healing and facilitating soft and hard tissue integration. The clinically proven efficacy of Straumann's materials shortens healing time, improves long-term stability of periodontal conditions, and makes minimally invasive surgeries possible, which benefits dentists and patients in many ways. |
 |
Henry Schein, Inc. offers various types of bone grafting materials that are employed in the treatment of periodontal disease for the regeneration of alveolar bone damaged because of chronic periodontitis. These products find their applications in the treatment of periodontal and implant-related disorders. | Henry Schein's bone grafting products support reliable bone regeneration and strengthen the jaw. This extensive product line allows dental professionals to select the appropriate products to address bone defects, thereby improving ease of treatment, outcomes, and overall periodontal health. |
 |
Nakanishi Inc. offers advanced oral care tools, such as high-speed handpieces and professional oral care tools, which are employed for periodontal therapy procedures like scaling, root planing, as well as plaque removal. | The company's oral hygiene products increase the efficiency of treatments through their ability to remove plaque and calculus without significant discomfort to the patient. These products have been designed for efficiency and functionality, which will increase clinical efficiency and the management of periodontal diseases through improved hygiene practices. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The periodontal disease treatment market includes several manufacturers, distributors, end users, and regulatory bodies, which operate together to develop, distribute, and allow for the adoption of periodontal treatment-related products. Major manufacturers such as Nakanishi, Yoshida, Ultradent Products, Geistlich Biomaterials, and Henry Schein Inc. offer high-end dental equipment, biomaterials, and surgical instruments. The distribution chain includes distributors such as Henry Schein Inc., BIOLASE Inc., MORITA, Regenity Ltd., and AMD LASERS. End users of these products include major health organizations and dental practices such as AdventHealth, Mount Sinai, Mayo Clinic, Cleveland Clinic, Johns Hopkins Medicine, and NHS Barts Health Hospitals. Regulatory authorities in this market, such as the US FDA, the UK EMA, and India's CDSCO, ensure that the quality of the product, its safety, effectiveness, and adherence to international standards are ensured; therefore, this market is also well-structured.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Periodontal Disease Treatment Market, By Product
Equipment currently holds the largest market share, as it is a requirement in the diagnosis, prevention, as well as treatment of periodontal diseases. Equipment like ultrasonic scalers, lasers, surgery items, imaging solutions, as well as treatment chairs, is commonly required in non-surgical as well as surgical periodontal treatment, which ensures steady sales of such items. Technological advancements related to solutions such as lasers, minimally invasive surgery, and computerized diagnostics have also aided in cementing this particular market share. Further, advancements related to steady improvements of such solutions to reduce treatment time, along with increasing usage of periodontal solutions, have aided in increasing this particular.
Periodontal Disease Treatment Market, By Disease Type
Gingivitis holds the largest share mainly because of its high prevalence, being the most widely reported disorder across all age groups. Being the first and most widespread stage of periodontal disease, gingivitis is generally noticed upon routine dental examinations, and this leads to a great number of people going for treatment. Since the disease can be reversed if treatment is given on time, there is a strong demand for preventive and non-surgical dental care procedures such as professional dental cleaning, scaling, and oral hygiene maintenance. More and more people are becoming aware of oral health and preventive dental care, which has made gingivitis the dominant disease type in the periodontal disease treatment market.
Periodontal Disease Treatment Market, By Treatment Type
Non-surgical treatment represents the highest segment of the market, by treatment type. It is widely used as a primary intervention for the management of periodontal conditions, especially gingivitis and early-stage periodontitis. On the other hand, minimally invasive and more affordable procedures such as scaling and root planing, professional dental cleaning, and antimicrobial therapy represent a preferable option for patients and dental professionals. Such treatments are usually performed on the occasion of a routine dental check and do not require complicated surgical infrastructure, which justifies their broad dispersal across dental clinics. The rising emphasis on prevention, early diagnosis, and continuous maintenance therapy further supports the leading position of non-surgical treatment within the periodontal disease treatment market.
Periodontal Disease Treatment Market, By End User
Hospitals hold a considerable share of the periodontal disease treatment end-user market. They can offer comprehensive periodontal and dental care in the same environment. They have the latest diagnostic imaging technology, top-notch surgical facilities, and expert dental professionals, enabling them to not only provide general treatments but also perform complex periodontal surgeries. Moreover, hospitals have a wide patient base, including advanced periodontal cases or patients with other health conditions who need coordinated, multidisciplinary care. Besides, the use of advanced treatment methods, compliance with strict infection control protocols, and higher patient trust in hospital-based services are some of the factors that have helped hospitals to maintain the dominant position in the periodontal disease treatment market.
REGION
Middle East & Africa to be fastest-growing region in the periodontal disease treatment market during forecast period
The Middle East and Africa (MEA) region is being recognized as the fastest-growing market for periodontal disease treatment as a result of demographic, epidemiological, and healthcare system factors. Due to low levels of oral hygiene awareness, high tobacco use, rising diabetes rates, and changing eating habits, especially in urban areas, the region is experiencing an increase in the prevalence of periodontal diseases. Rapid population growth and a large number of untreated patients also lead to the increased demand for periodontal therapies. Besides that, local governments in the Gulf Cooperation Council (GCC) countries and some African nations are raising their healthcare budgets and modernizing their dental infrastructures, which is facilitating access to advanced periodontal treatments such as scaling and root planing, laser therapy, and regenerative procedures. The growth of dental tourism in the UAE and Turkey, as well as the development of private dental clinics and specialty centers, is contributing to the market expansion.
PERIODONTAL DISEASE TREATMENT MARKET: COMPANY EVALUATION MATRIX
In the periodontal disease treatment market matrix, Dentsply Sirona (US) (Star) and Henry Schein, Inc. (US) (Star) lead with their unmatched global presence, strong brand recognition, and comprehensive portfolios of periodontal disease treatment. Yoshida Dental MFG. Co., Ltd. (Japan) (Emerging Leader) is rapidly gaining traction with its versatile medical gas and equipment products for therapeutic and diagnostic applications.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Dentsply Sirona (US)
- Henry Schein, Inc. (US)
- Nakanishi Inc. (Japan)
- Yoshida Dental MFG. Co., Ltd. (Japan)
- Institut Straumann Holdings AG (Switzerland)
- Envista Holdings Corporation (US)
- BIOLASE MG LLC (US)
- BEGO GmbH & Co. KG (Germany)
- Geistlich Pharma AG (Switzerland)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 2.71 Billion |
| Market Forecast in 2031 (Value) | USD 3.86 Billion |
| Growth Rate | CAGR of 6.2% from 2026-2031 |
| Years Considered | 2025-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Million/Billion), Volume (Thousands Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa, GCC Countries |
| Related Segment & Geographic Reports |
US Periodontal Disease Treatment Market APAC Periodontal Disease Treatment Market |
WHAT IS IN IT FOR YOU: PERIODONTAL DISEASE TREATMENT MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Volume Analysis | Market assessment by volume (units) for dental equipment used in digital dentures ecosystem |
|
| Product Analysis | Further breakdown of other applications in the market | Insights on other applications involved in the market |
| Company Information |
|
Insights on market share analysis by country |
| Geographic Analysis |
|
Country-level demand mapping for new product launches and localization strategy planning |
RECENT DEVELOPMENTS
- October 2025 : BIOLASE showcased a YSGG laser-assisted periodontitis treatment protocol at the AAP 2025 Corporate Forum, highlighting a minimally invasive approach that improves bacterial reduction, preserves healthy tissue, and enhances healing outcomes in periodontal pocket treatment.
- July 2025 : Envista expanded its manufacturing footprint with a new facility in China to strengthen regional supply, improve operational efficiency, and support growing demand for dental and periodontal care products in the Asia Pacific market.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study involved four major activities in estimating the current periodontal disease treatment market size. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the periodontal disease treatment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the periodontal disease treatment market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents for the periodontal disease treatment market is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global periodontal disease treatment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global periodontal disease treatment market was split into various segments and sub-segments based on:
- List of major players operating in the products market at the regional and/or country level
- Product mapping of various periodontal disease treatment manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from periodontal disease treatment (or the nearest reported business unit/product category)
- Revenue mapping of major players to be covered.
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global periodontal disease treatment market
Market Size Estimation (Bottom Up approach & Top down approach)
Data Triangulation
After arriving at the overall size of the global periodontal disease treatment market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Market Definition
Periodontal disease treatment refers to the medical interventions aimed at preventing, controlling, and treating the inflammation and damage caused by infections of the structures around the teeth, including the gums, periodontal ligament, and alveolar bone. Treatments typically range from non-surgical methods such as scaling and root planing (deep cleaning) to surgical procedures like flap surgery or bone grafting, depending on the severity of the disease. The goal is to eliminate the bacterial infection and halt the progression of the disease, thereby preserving the teeth and surrounding tissues.
Key Stakeholders
- Manufacturers and distributors of medical devices
- Periodontal Disease Treatment manufacturers
- Contract manufacturers of dental equipment
- Distributors of dental equipment
- Research and consulting firms
- Raw material suppliers of Periodontal Disease Treatment
- Dental hospitals and clinics
- Dental laboratories and associations
- Dental practitioners
- Dental laboratory technicians
- Healthcare institutions
- Diagnostic laboratories
- Hospitals and clinics
- Academic institutions
- Research institutions
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
Report Objectives
- To define, describe, and forecast the periodontal disease treatment market based on disease type, treatment type, end user, and region
- To forecast the market size based on five key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders, buying criteria, and conference and events
- To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall periodontal disease treatment market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To strategically profile key players in the periodontal disease treatment market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall periodontal disease treatment market
- To benchmark players within the market using the proprietary “Competitive Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
- To analyze the generative AI impact on the periodontal disease treatment market
Customization Options
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
GEOGRAPHIC ANALYSIS
- Further breakdown of the Rest of Europe periodontal disease treatment market into Russia, Switzerland, Denmark, Austria, and others
- Further breakdown of the Rest of Asia Pacific periodontal disease treatment market into South Korea, Taiwan, and others
- Further breakdown of the Rest of Latin America periodontal disease treatment market into Argentina, Colombia, Chile, Ecuador, and others
- Further breakdown of the Southeast Asia periodontal disease treatment market into Malaysia, Singapore, New Zealand, and others
COMPETITIVE LANDSCAPE ASSESSMENT
- Market share analysis, by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), which provides market shares of the top 3-5 key players in the periodontal disease treatment market
- Competitive leadership mapping for established players in the US
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Periodontal Disease Treatment Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Periodontal Disease Treatment Market